Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04227327
Title Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7) (HERMIONE-7)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Milano Bicocca
Indications

Her2-receptor negative breast cancer

Therapies

Abemaciclib + Letrozole

Abemaciclib + Anastrozole

Age Groups: adult | senior
Covered Countries


No variant requirements are available.